Popular Articles From: GE Oil & Gas Plans to Open an Advanced Manufacturing Facility in Jacksonville, Florida to GlobalWise Investments Shareholders Approve Proxy Slate Including Name Change to Intellinetics, Inc. and 1-7 Reverse Stock Split


2014/9/26
GE (NYSE:GE) Oil & Gas announced today plans to invest more than $50 million in a new advanced manufacturing facility located in Jacksonville, Florida.
Sign-up for GE Oil & Gas Plans to Open an Advanced Manufacturing Facility in Jacksonville, Florida investment picks
2014/7/24
Indiana University's Kelley School of Business announced today that it is providing customized graduate-level educational programs for information technology professionals as part of General Electric's (NYSE:GE) Information Technology Leadership Program.
Sign-up for GE Partners with Indiana University's Kelley School of Business for Early Career IT Leadership Program investment picks
2014/8/19
Now offered in 4-inch and 6-inch versions, the Lumination™ RS Series LED DownLight from GE Lighting provides a contractor-grade, energy-efficient lighting solution for residential and commercial spaces.
Sign-up for GE’s Lumination™ RS Series LED DownLights Provide Easy-to-Install Options for Retrofit Projects in Residential and Commercial Spaces investment picks
2014/9/17
Gemfields is pleased to announce that it has entered into a joint venture with East West Gem Investments Limited (‘ EWGI ’), a Jersey registered company, in order to progress opportunities in the Sri Lankan sapphire and gemstone sector via three Sri Lankan subsidiaries which will be 75% and 25% held by Gemfields and EWGI respectively.
Sign-up for Gemfields adds Sapphires from Sri Lanka to Colored Gemstone Portfolio investment picks
2014/7/9
SACRAMENTO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- GenCorp Inc. (NYSE:GY) today reported results for the second quarter ended May 31, 2014.
Sign-up for GenCorp Reports 2014 Second Quarter Results investment picks
2014/8/29
GROTON, Conn.
Sign-up for General Dynamics Delivers Submarine North Dakota To U.S. Navy on Schedule and Under Target Cost investment picks
2014/7/15
MINNEAPOLIS , July 15, 2014 /PRNewswire/ -- General Mills today inaugurated the company's first innovation, technology and quality center in China , signaling a commitment to drive greater innovation and investment in one of the company's largest growth markets.
Sign-up for General Mills opens new innovation center in China investment picks
Company Announces $100 Million Cost-Savings Plan from Streamlining its North American Supply Chain Full-year 2015 Targets Maintained; Operating Environment More Challenging MINNEAPOLIS , Sept.
Sign-up for General Mills Reports Fiscal 2015 First Quarter Results investment picks
2014/8/11
As Millennials become more established in their careers, they are generally not on the radar of most financial advisors, reveals new research from the Principal Financial Group ® .
Sign-up for Generation Y: The Untapped Market for Financial Advisors investment picks
NASHVILLE, Tenn.
Sign-up for Genesco Reports Second Quarter Fiscal 2015 Results investment picks
Genesis Energy, L.P. (NYSE: GEL) today announced the commencement of a registered underwritten public offering of 4,000,000 common units representing limited partner interests.
Sign-up for Genesis Energy, L.P. Announces Public Offering of Common Units investment picks
Genie Energy Ltd.
Sign-up for Genie Energy Signs Agreement for Additional Oil Shale Exploration in Mongolia investment picks
Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, today announced the start of a Phase 2 dose optimization trial for GEN-003, the Company’s immunotherapy candidate against herpes simplex-type 2 (HSV-2). “Consistent with our long-standing development plans, this Phase 2 trial will compare the best dose of GEN-003 from our Phase 1/2a trial to other combinations of protein and adjuvant to determine the optimal dose for future trials and potentially improve on the current profile of GEN-003,” said Seth Hetherington, MD, chief medical officer of Genocea.
Sign-up for Genocea Commences Phase 2 Dose Optimization Trial for GEN-003 HSV-2 Immunotherapy investment picks
Additional Data Acceptances Include Multiple Oncotype DX® Studies in Breast and Renal Cancers REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Presentation of Positive Results from Latest Prostate Cancer Clinical Validation Study at the European Society for Medical Oncology (ESMO) 2014 Congress investment picks
Gentiva Health Services, Inc. (NASDAQ:GTIV) (“Gentiva”) today announced that it has received a conditional proposal from Kindred Healthcare, Inc. (“Kindred”) (NYSE: KND) to acquire all of the outstanding shares of Gentiva common stock for $17.25 per share.
Sign-up for Gentiva Health Services Announces Receipt of Acquisition Proposal from Kindred Healthcare investment picks
2014/9/24
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the establishment of a research collaboration with the University of Florida and the University of Pennsylvania to develop a gene therapy for the treatment of a rare genetic disease that causes childhood blindness.
Sign-up for Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness investment picks
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) approved a supplement to expand the indication for Lumizyme ® (alglucosidase alfa). Lumizyme manufactured at the 4000L scale is now indicated for all Pompe patients of any age or phenotype.
Sign-up for Genzyme Receives Label Expansion for Lumizyme® (alglucosidase alfa) in the United States for the treatment of Pompe Disease investment picks
2014/9/8
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that its multiple sclerosis pipeline, which includes a new generation of investigational treatments in early development, will be featured during the 30 th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) being held in Boston Sept.
Sign-up for Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS investment picks
JASPER, Ind., Sept.
Sign-up for German American Bancorp, Inc. to Present at the INVESTIndiana Equity Conference investment picks
Getty Realty Corp.
Sign-up for Getty Realty Corp. Announces Results for the Second Quarter 2014 investment picks
Gilbarco Veeder-Root, the worldwide leader in retail petroleum technology, and VeriFone Systems, Inc. (NYSE: PAY), the global leader in secure electronic payment solutions, today announced that they are partnering to offer next generation forecourt payment solutions and to create the largest at-pump interactive digital media network worldwide.
Sign-up for Gilbarco and VeriFone Join Forces to Offer Payment Solutions and Services and Digital Media to Convenience and Fuel Retailers investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from a Phase 2 study evaluating simtuzumab, an investigational inhibitor of lysyl oxidase-like-2 (LOXL2), in combination with gemcitabine for patients with previously untreated advanced pancreatic cancer.
Sign-up for Gilead Announces Data From Phase 2 Study of Simtuzumab for Previously Untreated Pancreatic Cancer investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has signed non-exclusive licensing agreements with seven India-based generic pharmaceutical manufacturers to expand access to its chronic hepatitis C medicines in developing countries.
Sign-up for Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Glimcher Realty Trust (“Glimcher”) (NYSE: GRT) concerning the acquisition by Washington Prime.
Sign-up for GLIMCHER REALTY SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Washington Prime investment picks
Global data center services provider CyrusOne (NASDAQ: CONE) announced today that it has added CFR Solutions as a new CyrusOne Express customer.
Sign-up for Global Data Center Services Provider CyrusOne Selected by CFR Solutions investment picks
2014/8/19
http://media.marketwire.com/attachments/201309/188572_globalnewlogo.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1138811&ProfileId=051205&sourceType=1 VIRGINIA BEACH, VA --
Sign-up for Global Holdings, Inc. (GBHD) Grows Strawberries for Domestic / International Produce Markets investment picks
2014/9/15
http://media.marketwire.com/attachments/201309/188572_globalnewlogo.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144550&ProfileId=051205&sourceType=1 VIRGINIA BEACH, VA --
Sign-up for Global Holdings, Inc.'s (GBHD) Legal Suits Dismissed investment picks
Interactive B2B Website Receives Recognition for Achievement in Design, Technology, Innovation, Interactivity, Content, Copywriting and Ease of Use PORT WASHINGTON, N.Y. , Sept.
Sign-up for Global Industrial Awarded Prestigious B2B Standard of Excellence Award by the Web Marketing Association investment picks
GlobalWise Investments, Inc. ( OTCQB: GWIV ) (OTCQB: INLX) and its wholly owned subsidiary Intellinetics, Inc. -- a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (ECM) systems in both the public and private sectors --
Sign-up for GlobalWise Investments Shareholders Approve Proxy Slate Including Name Change to Intellinetics, Inc. and 1-7 Reverse Stock Split investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: GE Oil & Gas Plans to Open an Advanced Manufacturing Facility in Jacksonville, Florida to GlobalWise Investments Shareholders Approve Proxy Slate Including Name Change to Intellinetics, Inc. and 1-7 Reverse Stock Split
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices